Nicole Barna, See Remarks at Codiak BioSciences, Inc. (CDAK), sold 836 shares at $0.58 ($485) on 2023-01-20, disclosed to the SEC on 2023-01-23.
Open-market sale of $485 CDAK by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDAK | BUY | 2022-02-07 | $50K | — | Filing → |